Top Markets
Coin of the day
Tianjin Ringpu Bio-Technology Co.,Ltd. Tianjin Ringpu Bio-Technology Co.,Ltd.

Tianjin Ringpu Bio-Technology Co.,Ltd.

300119
Clasificación en acciones #8815
Established in 1998 and based in Tianjin, China, Tianjin Ringpu Bio-Technology... Established in 1998 and based in Tianjin, China, Tianjin Ringpu Bio-Technology Co.,Ltd. focuses on the research, development, manufacturing, and commercialization of a broad spectrum of animal health solutions. Their product portfolio includes veterinary biologicals, pharmaceutical formulations, functional feed additives, and active pharmaceutical ingredients (APIs) for the Chinese market. The company provides a wide array of vaccines and medications for livestock, particularly poultry and swine. They also offer a comprehensive line of pet care products, such as inactivated rabies vaccines, recombinant canine-alpha interferon, inhalation anesthetics like isoflurane and sevoflurane for dogs and cats, cefquinoxime sulfate injections for bacterial infections, and cardiac treatments including napril chewable tablets. For waterfowl, their specialized offerings include live and inactivated duck tempusu vaccines, purified egg yolk antibodies for gosling plague and duck viral hepatitis, duck infectious serositis inactivated vaccines, as well as injectable and soluble powder treatments like florfenicol and kanamycin. Furthermore, Ringpu develops antifungal products featuring natural plant extracts, immune polysaccharides, probiotics (such as Clostridium butyricum and Lactobacillus plantarum), antibacterial peptides, enzyme preparations, and acidulants. Their disinfection and cleaning range comprises potassium hydrogen persulfate composite powder, various quaternary ammonium compounds (e.g., benzyl trimethyl ammonium chloride, deca methyl ammonium bromide), sodium dichloroisocyanurate, and iodine glycerin solutions. The company's API production includes crucial ingredients like tilmicosin, tilmicosin phosphate, monbutone, tidiroxine, florfenicol, vonimulin hydrochloride, and gamimycin.
Precio por acción
$2.51
Última sincronización: 2026-08-28
Capitalización bursátil
$1.17B
Cambio (1 día)
0.58%
Cambio (1 año)
-20.26%
País
CN
Comercio Tianjin Ringpu Bio-Technology Co.,Ltd. (300119)

Categoría

Historial del precio de la acción de Tianjin Ringpu Bio-Technology Co.,Ltd. (300119)
Precio más alto de cierre: $2.65 el 2026-08-01

Precio más bajo de cierre: $1.95 el 2010-09-01
Historial del precio de la acción de Tianjin Ringpu Bio-Technology Co.,Ltd. desde 2010 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -1.80%
2025 1.96%
2024 15.02%
2023 -17.64%
2022 -22.18%
2021 16.56%
2020 51.65%
2019 93.31%
2018 -40.25%
2017 -30.26%
2016 -17.35%
2015 83.56%
2014 -18.19%
2013 45.92%
2012 9.65%
2011 -39.30%
2010 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$171.67 -
DE
$166.36 31.46%
DE
$37.84 25.87%
JP
$222.33 27.49%
CH
$21.19 17.16%
IN